Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Mesenchymal stem cells expressing vasoactive intestinal peptide ameliorate symptoms in a model of chronic multiple sclerosis.
Delayed onset adenosine deaminase deficiency associated with acute disseminated encephalomyelitis.
On dihydroorotate dehydrogenases, their inhibitors and uses.
Nerve Conduction Velocity Is Regulated by the Inositol Polyphosphate-4-Phosphatase II Gene.
Multiple sclerosis: Risk of comorbid inflammatory diseases in MS might not be genetically determined.
The NOX1/4 Inhibitor GKT136901 as Selective and Direct Scavenger of Peroxynitrite.
Atypical guillain-barré syndrome misdiagnosed as lumbar spinal stenosis.
Endogenous retroviruses and multiple sclerosis--new pieces to the puzzle.
Olive oil phenols and neuroprotection.
High risk of MS in Iranian immigrants in Gothenburg, Sweden.
An Inventory of Short Term and Long Term Changes in Gene Expression Under Interferon β Treatment of Relapsing Remitting MS Patients.
Improved ability to work after one year of natalizumab treatment in multiple sclerosis. Analysis of disease-specific and work-related factors that influence the effect of treatment.
Exercise and quality of life in women with multiple sclerosis.
RORγt(+) cells selectively express redundant cation channels linked to the Golgi apparatus.
New Analysis Suggests Aubagio® (teriflunomide) Slows Brain Atrophy in People with Relapsing Multiple Sclerosis
Clinical trials in progressive multiple sclerosis: lessons learned and future perspectives.
Liver X receptors alpha and beta promote myelination and remyelination in the cerebellum.
Improved self-efficacy in persons with relapsing remitting multiple sclerosis after an intensive social cognitive wellness program with participation of support partners: a 6-months observational study.
Patient page. Multiple sclerosis and vitamin D.
A randomized blinded trial of combination therapy with cyclophosphamide in patients-with active multiple sclerosis on interferon beta.
DQB1*0602 rather than DRB1*1501 confers susceptibility to multiple sclerosis-like disease induced by proteolipid protein (PLP).
Effect of treatment with interferon beta-1a on changes in voxel-wise magnetization transfer ratio in normal appearing brain tissue and lesions of patients with relapsing-remitting multiple sclerosis: a 24-week, controlled pilot study.
Vorinostat, a histone deacetylase inhibitor, suppresses dendritic cell function and ameliorates experimental autoimmune encephalomyelitis.
Intermittent feeding attenuates clinical course of experimental autoimmune encephalomyelitis in C57BL/6 mice.
Organic solvents as risk factor for autoimmune diseases: a systematic review and meta-analysis.

Pages